Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Outcomes Assessments, Patients”

739 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 739 results

Not applicableStudy completedNCT01168583
What this trial is testing

Fluid Balance and Clinical Outcomes

Who this might be right for
Fluid BalanceInput and OutputInflammatory Mediators+2 more
University of Florida 300
Not applicableStudy completedNCT03832283
What this trial is testing

Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-Depression

Who this might be right for
DepressionDepressive Disorder, Major
University of Chicago 4,161
Not applicableLooking for participantsNCT06473259
What this trial is testing

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerHormone Sensitive Prostate CancerMetastatic Tumor
Santa Chiara Hospital 3,000
Not applicableStudy completedNCT01860456
What this trial is testing

TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study

Who this might be right for
Chronic Myeloid Leukemia
University of Pisa 412
Not applicableStudy completedNCT00805688
What this trial is testing

Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 100
Not applicableNot Yet RecruitingNCT06521086
What this trial is testing

Optimizing Recovery in Trauma Patients by Integrating Enhanced Nutrition Delivery

Who this might be right for
TraumaCritical Illness
Duke University 60
Not applicableStudy completedNCT07192770
What this trial is testing

G-CSF-Induced Bone Pain and Supportive Care Approaches

Who this might be right for
Solid TumorsChemotherapy-induced Neutropenia
Ankara Etlik City Hospital 225
Not applicableEnded earlyNCT03053453
What this trial is testing

Evaluation of Patient Reported Outcomes (PRO) After Total Knee Arthroplasty (TKA) Under Spinal Anesthesia

Who this might be right for
Knee Injuries
NYU Langone Health 52
Not applicableStudy completedNCT06846957
What this trial is testing

ESSENCE is a Quality Improvement Study That Evaluates the Impact of Ada's AI-powered Core Symptom Assessment Technology on Clinical Workflow and Individual Healthcare Guidance, Following the November 2021 Integration of the Tool Into the CUF Hospital Network. Study Duration Nov 2024-Oct 2025

Who this might be right for
Symptom Assessment
Ada Health GmbH 1,470
Not applicableStudy completedNCT06164899
What this trial is testing

Long-term Evaluation of Outcomes of Patients Undergoing Autologous Bone Marrow Concentrate Infiltration vs. Hyaluronic Acid

Who this might be right for
Knee Osteoarthritis
Istituto Ortopedico Rizzoli 60
Not applicableLooking for participantsNCT07475767
What this trial is testing

Ultrasound Indicators of Nutritional Status and Treatment Outcomes in Surgical Patients in the Intensive Care Unit

Who this might be right for
Nutritional StatusMuscle Thickness of the Quadriceps FemorisFrailty
Osijek University Hospital 50
Not applicableUnknownNCT06101758
What this trial is testing

Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study

Who this might be right for
Liver CirrhosisNon-Alcoholic Fatty Liver DiseaseHepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 125
Not applicableStudy completedNCT05671367
What this trial is testing

Association Between Microvascular Resistance and Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Microvascular DysfunctionHypertrophic Obstructive CardiomyopathyMicrocirculation Resistance
China National Center for Cardiovascular Diseases 340
Not applicableEnded earlyNCT00617214
What this trial is testing

Schizophrenic Patients Taking Part in Integrated Care Program

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreni-form Disorder+2 more
AstraZeneca 20
Not applicableUnknownNCT05416047
What this trial is testing

An Investigation of Frailty Markers and Outcomes in Patients Requiring Emergency Laparotomy

Who this might be right for
FrailtySurgerySarcopenia
NHS Greater Glasgow and Clyde 150
Not applicableStudy completedNCT00212238
What this trial is testing

Enhanced Internet Behavior Therapy for Treating Obesity

Who this might be right for
Obesity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 100
Not applicableUnknownNCT05930366
What this trial is testing

Comparative Evaluation of Microsurgery vs Diode Laser Technique of Gingival Depigmentation

Who this might be right for
Gingival PigmentationMelanosis
Postgraduate Institute of Dental Sciences Rohtak 22
Not applicableUnknownNCT05716269
What this trial is testing

Visual Outcomes and Patient Satisfactory After PanOptix Implantation in Hyperopic Cataract Patients

Who this might be right for
CataractHyperopia
Peking University Third Hospital 44
Not applicableStudy completedNCT06702150
What this trial is testing

Nursing Model and Health Outcomes of Elderly People with Multimorbidity: a Quasi-experimental Study

Who this might be right for
MultimorbidityAgedPatient Outcome Assessment
Hospital da Luz, Portugal 206
Post-approval studies (Phase 4)Study completedNCT01534182
What this trial is testing

Evaluation of Patient Reported Outcomes in RRMS Patients Candidates for MS Therapy Change and Transitioned to Fingolimod 0.5 mg (EPOC)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 298
Load More Results